A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report.

Jing-Wen ChenJing-Yi ZhanSi-Ping LiangXiao-Dan WangChang-Song LinQiang Xu

Published in: International journal of rheumatic diseases (2023)

During the 19 months of telitacicept treatment (160 mg once weekly), PLN reduced blood system damage and proteinuria without increasing the risk of infection.

Keyphrases

oxidative stress
case report
replacement therapy